Johnson & Johnson puts its Cordis vascular device business on the auction block after years of sluggish growth.
Healthcare giant Johnson & Johnson (NYSE:JNJ) is looking to divest its Cordis business after years of lackluster sales for the company's stents, catheters and other vascular devices, according to a report from the Wall Street Journal.
California's Sequent Medical begins enrolling patients in an IDE clinical trial of its Web aneurysm embolization system.
Medtech company Sequent Medical enrolled the 1st 4 patients in a new U.S. clinical trial aimed at winning FDA approval for its Web aneurysm protection implant.
The Web implant is made of a Nitinol mesh that is delivered in a "stent-like" manner and deployed into the pouch formed by an aneurysm in order to prevent blood from flowing in. The device already has approve in the European Union.
Georgia-based Theragenics has about 50 new positions to fill as it prepares to begin manufacturing in Costa Rica. The company cut nearly 140 workers from its Texas-based Galt Medical operations earlier this year.
Surgical devices maker Theragenics is looking to add some employees overseas at it prepares to ramp up manufacturing at a new facility in Costa Rica, part of larger outsourcing plans that included cuts in the U.S.
Final results from Covidien's DEFINITIVE LE study, originally closed in 2012, finally appear in the Journal of American College of Cardiology, Cardiovascular Interventions.
It may have taken 2 years but final results from Covidien's (NYSE:COV) DEFINITIVE LE study finally appeared in the Journal of the American College of Cardiology's Cardiovascular Interventions issue.
Indiana-based Cook recalls its CloverSnare vascular retrieval snares after at least 6 complaints that the devices came apart during use.
Cook Medical announced this week that it recalled nearly 700 units of its CloverSnare 4-Loop Vascular Retrieval Snare devices after receiving complaints that the devices came apart during use.
New York-based Transluminal Technologies touts its 1st CE Mark for the 1st-of-its-kind Velox CD vascular closure system.
Transluminal Technologies is ready to take on the European market with CE Mark approval for its flagship Velox CD vascular closure devices.